1st Course in Genetics, Medical Technologies & Public Health Policies 2008

Submitted: Saturday 6th of February 2010 08:19:06 PM
Submitted by: egf
Language: English
Educational levels: expert, qc2, qc3



The confluence of molecular biology, biomedical engineering, and clinical medicine has led to a rapidly expanding range of new opportunities for patient care in many areas of medicine, among which, perhaps most visibly, is medical genetics. However such radical advances not only give rise to changes in the practice of medicine, but require a fresh look at the bioethical implications of the new practices, and the adequacy of existing legal and policy institutions. This course will explore those issues from European and global perspectives. Topics of discussion will include the application of ethical concepts in genetics


SAFE arose in response to Expressions of Interest in the then new framework 6 programme of the European commission, and was based on an informal network of researchers, clinicians, social scientists and SMEs who had worked together with the collective aim of delivering non-invasive prenatal diagnosi ...
Screening for trisomy 21, often in conjunction with screening for neural tube defects, by the measurement of second trimester maternal serum biochemical markers has become an established part of obstetric practice in many countries. Although trisomy 21 screening protocols vary from centre to centre ...
The ability to diagnose genetic disorders by the use of noninvasive molecular methods is a goal that many are striving to achieve. Over the past 10 years it has been demonstrated that noninvasive prenatal detection of fetal genetic targets and chromosomal aneuploidies is possible by analysis of cir ...
Any collection of biological samples requires the informed consent of patient/donor. It does not matter if this collection of samples is for research or diagnostic purpose. For any project using human material specifically collected for research, the “Convention for the protection of human rights ...
By far the most common indication for prenatal diagnosis concerns the increased risk for reproductively older women bearing a child with trisomy 21 Down’s syndrome. The recent change in demography in European countries with many women today delaying childbearing until their late 30ths was also on ...
The main problem of noninvasive prenatal diagnosis on maternal plasma is the predominant presence of maternal DNA (>95%), which competes with the fetal one during the amplification process. This makes particularly difficult the identification of paternally inherited fetal DNA sequences which may dif ...
Proteomics is the study of the complete protein content of a tissue, cell or biological fluid, and assessment of changes in protein expression including responses to stimuli (e.g. induction by hormones), or changes induced by disease. A key aspect of current proteomics has been technology to separat ...

Similar resources

Loading ...

IMS Metadata


abnormal, affected, agarose gel, algorithm, allele, allograft, alphafetoprotein, amniocentesis, Analysis of the entire coding region: Sequence analysis, aneuploidy, annealing, antibody, apoptosis, Array genomic hybridization, association, base, base pair, beta, bioinformatics, biomarker, biotechnology, carrier, carrier screening, cell, cell culture, chorionic villus sampling, chromatin, chromosome, complement, Complementary DNA, conception, concordance, congenital, cordocentesis, correlation, cpg island, cytosine, de novo, deoxyribonucleic acid, discordant, disruption, DNA banking, DNA methylation, dna polymerase, dna probe, electrophoresis, epigenetics, euploid, excision, false-positive, familial, fetus, fixed, fluorescent in situ hybridization, frequency, g band, gel electrophoresis, gene, gene expression, genetic disease, genetics, genome, genomic dna, genomic imprinting, genomics, genotype, heterozygous, hormone, human leucocyte antigen, hybrid, hybridization, immune system, incidence, informed consent, inherited, karyotype, ligation, linkage, long interspersed nuclear element, marker, maternal, maternal contamination, maternal serum screening, messenger rna, methylation, microarray, microsatellite, miscarriage, mutant, mutation, nucleus, ovum, pedigree, peptide, phase, phenol enhanced reassociation technique, placenta, polymerase chain reaction, polymorphism, population, prenatal diagnosis, prenatal screening, prevalence, primer, probe, processing, protein, proteomics, quantitative, recessive, recurrence risk, restriction enzyme, ribonucleic acid, risk assessment, screening, sensitivity, sequence, single nucleotide polymorphism, specie, specificity, sperm, stem cell, syndrome, transcription, trisomy, trophoblast, ultrasound, unaffected, uracil, uterus, variance, virus, western blot, y-chromosome



Terms of use

This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License. Read more.